1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "279215-43-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-119322


    Potassium Channel Metabolic Disease
    Tifenazoxide (NN414) is a potent, orally active and SUR1/Kir6.2 selective K ATP channels opener. Tifenazoxide has antidiabetic effect, can inhibit glucose stimulated insulin release in vitro and in vivo, and has a beneficial effect on glucose homeostasis.